Gainers
- Hepion Pharmaceuticals, Inc. HEPA rose 41.6% to $7.05 in pre-market trading following 8-K filing that showed results from expanded study of CRV431 for NASH indicated prevention of liver fibrosis was greater than 4 other leading NASH candidates.
- Conatus Pharmaceuticals Inc CNAT rose 34.7% to $0.55 in pre-market trading after the company and Histogen entered into a definitive merger agreement.
- MACOM Technology Solutions Holdings Inc MTSI shares rose 12.3% to $29.50 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 EPS and sales guidance above analyst estimates.
- Inovio Pharmaceuticals, Inc. INO shares rose 11.2% to $4.85 in pre-market trading after falling 18.05% on Tuesday.
- NanoViricides, Inc. NNVC rose 10.9% to $9.10 in pre-market trading after dropping 48.07% on Tuesday.
- FuelCell Energy, Inc. FCEL rose 10% to $1.99 in pre-market trading after climbing 17.53% on Tuesday.
- Brinker International, Inc. EAT shares rose 9.3% to $47.85 in pre-market trading following better-than-expected Q2 earnings.
- Happiness Biotech Group Limited HAPP rose 7.8% to $5.24 in pre-market trading after gaining 5.19% on Tuesday.
- Tata Motors Limited TTM rose 5.2% to $13.19 in pre-market trading.
- General Electric Company GE rose 5% to $12.31 in pre-market trading following upbeat Q4 earnings.
- Co-Diagnostics, Inc. CODX rose 5% to $2.72 in pre-market trading after declining 24.49% on Tuesday.
- ObsEva SA OBSV rose 5% to $4.03 in pre-market trading.
- Novavax, Inc. NVAX rose 4.6% to $7.50 in pre-market trading after declining 15.65% on Tuesday.
- Agile Therapeutics, Inc. AGRX rose 4.6% to $4.10 in pre-market trading after surging 14.96% on Tuesday.
- PG&E Corporation PCG rose 4.2% to $15.57 in pre-market trading after gaining 6.48% on Tuesday.
- Maxim Integrated Products Inc MXIM rose 3.9% to $64.50 in pre-market trading after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 EPS guidance above analyst estimates.
- Alpha Pro Tech, Ltd. APT rose 3.9% to $5.92 in pre-market trading after dropping 25.97% on Tuesday.
- Teva Pharmaceutical Industries Limited TEVA rose 3.4% to $10.55 in pre-market trading after reporting FDA approval of AJOVY Injection Autoinjector.
- Apple Inc. AAPL rose 2.3% to $324.85 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above estimates.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Avinger Inc AVGR fell 18.1% to $0.71 in pre-market trading. Avinger priced its 6.4 million share underwritten public offering of common stock at $0.70 per share.
- Biopharmx Corp BPMX shares fell 10.1% to $0.70 in pre-market trading after the company and Timber Pharmaceuticals announced entry into a merger agreement.
- Biohaven Pharmaceutical Holding Co Ltd BHVN fell 9.6% to $51.00 in pre-market trading after the company reported a $250 million common stock offering.
- Xilinx, Inc. XLNX fell 7.7% to $91.00 in pre-market trading after the company reported worse-than-expected Q3 sales results. The company also issued Q4 sales guidance below estimates.
- eBay Inc. EBAY fell 5.3% to $34.31 in pre-market trading after the company issued Q1 sales guidance under analyst estimates.
- Cerus Corporation CERS fell 4.8% to $3.95 in pre-market trading after the company announced a public offering of 7.5 million shares of common stock.
- Hecla Mining Company HL shares fell 4.5% to $2.75 in pre-market trading after declining 9.43% on Tuesday.
- Advanced Micro Devices, Inc. AMD fell 4.2% to $48.41 in pre-market trading after the company issued weak sales forecast.
- Huazhu Group Limited HTHT fell 4% to $33.50 in pre-market trading after gaining 5.73% on Tuesday.
- Denali Therapeutics Inc. DNLI fell 3.4% to $24.00 in pre-market trading. Denali Therapeutics priced 7.8 million share public offering of common stock at $23 per share.
- Tenet Healthcare Corporation THC fell 3.3% to $33.72 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPre-Market OutlookMarketsTrading IdeasHealth CareHealth Care EquipmentPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in